These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


287 related items for PubMed ID: 10953023

  • 1. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia.
    Eberhardt RT, Forgione MA, Cap A, Leopold JA, Rudd MA, Trolliet M, Heydrick S, Stark R, Klings ES, Moldovan NI, Yaghoubi M, Goldschmidt-Clermont PJ, Farber HW, Cohen R, Loscalzo J.
    J Clin Invest; 2000 Aug; 106(4):483-91. PubMed ID: 10953023
    [Abstract] [Full Text] [Related]

  • 2. Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice.
    Dayal S, Arning E, Bottiglieri T, Böger RH, Sigmund CD, Faraci FM, Lentz SR.
    Stroke; 2004 Aug; 35(8):1957-62. PubMed ID: 15178827
    [Abstract] [Full Text] [Related]

  • 3. Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice.
    Weiss N, Heydrick S, Zhang YY, Bierl C, Cap A, Loscalzo J.
    Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):34-41. PubMed ID: 11788458
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of low and high dose folic acid on endothelial dysfunction in a murine model of mild hyperhomocysteinaemia.
    Clarke ZL, Moat SJ, Miller AL, Randall MD, Lewis MJ, Lang D.
    Eur J Pharmacol; 2006 Dec 03; 551(1-3):92-7. PubMed ID: 17045583
    [Abstract] [Full Text] [Related]

  • 5. Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice.
    Dayal S, Bottiglieri T, Arning E, Maeda N, Malinow MR, Sigmund CD, Heistad DD, Faraci FM, Lentz SR.
    Circ Res; 2001 Jun 08; 88(11):1203-9. PubMed ID: 11397788
    [Abstract] [Full Text] [Related]

  • 6. Moderate hyperhomocysteinemia decreases endothelial-dependent vasorelaxation in pregnant but not nonpregnant mice.
    Powers RW, Gandley RE, Lykins DL, Roberts JM.
    Hypertension; 2004 Sep 08; 44(3):327-33. PubMed ID: 15249551
    [Abstract] [Full Text] [Related]

  • 7. Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient mice.
    Lentz SR, Erger RA, Dayal S, Maeda N, Malinow MR, Heistad DD, Faraci FM.
    Am J Physiol Heart Circ Physiol; 2000 Sep 08; 279(3):H970-5. PubMed ID: 10993757
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction.
    Weiss N, Zhang YY, Heydrick S, Bierl C, Loscalzo J.
    Proc Natl Acad Sci U S A; 2001 Oct 23; 98(22):12503-8. PubMed ID: 11606774
    [Abstract] [Full Text] [Related]

  • 9. Peroxisome proliferator ameliorates endothelial dysfunction in a murine model of hyperhomocysteinemia.
    Sood HS, Hunt MJ, Tyagi SC.
    Am J Physiol Lung Cell Mol Physiol; 2003 Feb 23; 284(2):L333-41. PubMed ID: 12533311
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F.
    Eur J Pharmacol; 2005 Mar 21; 511(1):53-64. PubMed ID: 15777779
    [Abstract] [Full Text] [Related]

  • 11. Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.
    Dayal S, Rodionov RN, Arning E, Bottiglieri T, Kimoto M, Murry DJ, Cooke JP, Faraci FM, Lentz SR.
    Am J Physiol Heart Circ Physiol; 2008 Aug 21; 295(2):H816-25. PubMed ID: 18567702
    [Abstract] [Full Text] [Related]

  • 12. Hyperhomocysteinemia and hyperglycemia induce and potentiate endothelial dysfunction via μ-calpain activation.
    Cheng Z, Jiang X, Pansuria M, Fang P, Mai J, Mallilankaraman K, Gandhirajan RK, Eguchi S, Scalia R, Madesh M, Yang X, Wang H.
    Diabetes; 2015 Mar 21; 64(3):947-59. PubMed ID: 25352635
    [Abstract] [Full Text] [Related]

  • 13. Nitrotyrosinylation, remodeling and endothelial-myocyte uncoupling in iNOS, cystathionine beta synthase (CBS) knockouts and iNOS/CBS double knockout mice.
    Kundu S, Kumar M, Sen U, Mishra PK, Tyagi N, Metreveli N, Lominadze D, Rodriguez W, Tyagi SC.
    J Cell Biochem; 2009 Jan 01; 106(1):119-26. PubMed ID: 19021146
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation.
    Jiang X, Yang F, Tan H, Liao D, Bryan RM, Randhawa JK, Rumbaut RE, Durante W, Schafer AI, Yang X, Wang H.
    Arterioscler Thromb Vasc Biol; 2005 Dec 01; 25(12):2515-21. PubMed ID: 16210565
    [Abstract] [Full Text] [Related]

  • 16. Genetic background conversion ameliorates semi-lethality and permits behavioral analyses in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia.
    Akahoshi N, Kobayashi C, Ishizaki Y, Izumi T, Himi T, Suematsu M, Ishii I.
    Hum Mol Genet; 2008 Jul 01; 17(13):1994-2005. PubMed ID: 18364386
    [Abstract] [Full Text] [Related]

  • 17. Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia.
    Dayal S, Wilson KM, Leo L, Arning E, Bottiglieri T, Lentz SR.
    Blood; 2006 Oct 01; 108(7):2237-43. PubMed ID: 16804115
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Homocysteine impaired endothelial function through compromised vascular endothelial growth factor/Akt/endothelial nitric oxide synthase signalling.
    Yan TT, Li Q, Zhang XH, Wu WK, Sun J, Li L, Zhang Q, Tan HM.
    Clin Exp Pharmacol Physiol; 2010 Nov 01; 37(11):1071-7. PubMed ID: 20698860
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.